Article Cited by others


Metronomic chemotherapy

Maiti Rituparna

Year : 2014| Volume: 5| Issue : 3 | Page no: 186-192

   This article has been cited by
1 The telomere-binding protein TRF2 is required for metronomic therapeutic effects of gemcitabine and capecitabine
Wei-Ping Lee,Keng-Hsin Lan,Chung-Pin Li,Yee Chao,Ming-Chih Hou,Han-Chieh Lin,Shou-Dong Lee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017; 1863(4): 917
[Pubmed]  [Google Scholar] [DOI]
2 A Commentary: Herbal Medicine Offers Great Potential in Support of Metronomic Cancer Therapy
Clara Bik-San Lau,Chun-Kwok Wong,Ping-Chung Leung
Journal of Cancer Therapy. 2017; 08(02): 86
[Pubmed]  [Google Scholar] [DOI]
3 The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field
T. B. Gaspar,J. Henriques,L. Marconato,F. L. Queiroga
Veterinary and Comparative Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model
Amr S. Abu Lila,Naoto Moriyoshi,Masakazu Fukushima,Cheng-Long Huang,Hiromi Wada,Tatsuhiro Ishida
Cancer Letters. 2016;
[Pubmed]  [Google Scholar] [DOI]
5 Combinatorial immunotherapy strategies for hepatocellular carcinoma
Maria Tagliamonte,Annacarmen Petrizzo,Maria Lina Tornesello,Gennaro Ciliberto,Franco M Buonaguro,Luigi Buonaguro
Current Opinion in Immunology. 2016; 39: 103
[Pubmed]  [Google Scholar] [DOI]
6 A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma†
R. Finotello,J. Henriques,S. Sabattini,D. Stefanello,R. Felisberto,S. Pizzoni,R. Ferrari,L. Marconato
Veterinary and Comparative Oncology. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
7 Metronomic chemotherapy and nanocarrier platforms
Amr S. Abu Lila,Tatsuhiro Ishida
Cancer Letters. 2016;
[Pubmed]  [Google Scholar] [DOI]
8 Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
Ursula Winter,Hebe A. Mena,Soledad Negrotto,Eloisa Arana,Guillem Pascual-Pasto,Viviana Laurent,Mariona Suñol,Guillermo L. Chantada,Angel M. Carcaboso,Paula Schaiquevich,Francesco Bertolini
PLOS ONE. 2016; 11(7): e0160094
[Pubmed]  [Google Scholar] [DOI]
9 Cancer vaccines for hepatocellular carcinoma: future directions
Franco M Buonaguro,Luigi Buonaguro
Immunotherapy. 2016; 8(4): 391
[Pubmed]  [Google Scholar] [DOI]
10 Refractory Choriocarcinoma: Complete Response With Oral Etoposide
Manikandan Dhanushkodi,Trivadi Ganesan,Tenali Gnana Sagar
Journal of Global Oncology. 2016; : JGO006049
[Pubmed]  [Google Scholar] [DOI]
11 Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer
Roberto Petrioli,Giandomenico Roviello,Anna Ida Fiaschi,Letizia Laera,Salvatora Tindara Miano,Daniele Marrelli,Franco Roviello,Vincenzo Bianco,Edoardo Francini
Future Oncology. 2015; 11(18): 2563
[Pubmed]  [Google Scholar] [DOI]
12 From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
Karolina Vernmark,Maria Albertsson,Bergthor Björnsson,Thomas Gasslander,Per Sandström,Xiao-Feng Sun,Annika Holmqvist
BMC Cancer. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]
13 Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
Irina Kareva,David J. Waxman,Giannoula Lakka Klement
Cancer Letters. 2015; 358(2): 100
[Pubmed]  [Google Scholar] [DOI]
14 Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma
Zeng Wang-Yuan,Zeng Jiang-Zheng,Yan-Da Lu,Xin-Bao Hao,Tao Hong,Fen Huang,Jun-Hua Lei,Zhi-Hui He,Mei-zhu Huang
International Journal of Hyperthermia. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
15 Head and neck cancer: metronomic chemotherapy
Francesca De Felice,Daniela Musio,Vincenzo Tombolini
BMC Cancer. 2015; 15(1)
[Pubmed]  [Google Scholar] [DOI]
16 Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
Gabriella Ferrandina,Giacomo Corrado,Floriana Mascilini,Paola Malaguti,Riccardo Samaritani,Mariagrazia Distefano,Valeria Masciullo,Alessia Di Legge,Antonella Savarese,Giovanni Scambia
BMC Cancer. 2014; 14(1): 947
[Pubmed]  [Google Scholar] [DOI]


Read this article